MACS® GMP Recombinant Human IL-7

Interleukin 7 (IL-7) is a pleiotropic cytokine with central roles in modulating T cell development and peripheral T cell homeostasis. IL-7 can act both as a T cell growth factor as well as a critical anti-apoptotic survival factor for naive and memory T cells.

MACS GMP Recombinant Human IL-7 is designed for ex vivo cell culture processing. No animal- or human-derived materials were used for the manufacture of this product, unless otherwise stated in the respective Certificate of Origin. The product is lyophilized without carrier protein or preservatives.

Choose your product:

Related products for MACS® GMP Recombinant Human IL-7

Product data and images for MACS® GMP Recombinant Human IL-7
Figure 1

Mass spectrometry analysis (ESI-MS) of MACS GMP Recombinant Human IL-7. The peak corresponds to the calculated molecular mass of 17382 Da.

Figure 2

Human IL-7 biological activity. Activity of Human IL-7, GMP grade (blue bar) was compared to another commercially available product (black bar).

Figure 3

MACS GMP Recombinant Human IL-7 batch-to-batch variability. Activity of three different production batches of Human MACS GMP IL-7.

Specifications for MACS® GMP Recombinant Human IL-7
Overview

Interleukin 7 (IL-7) is a pleiotropic cytokine with central roles in modulating T cell development and peripheral T cell homeostasis. IL-7 can act both as a T cell growth factor as well as a critical anti-apoptotic survival factor for naive and memory T cells.

MACS GMP Recombinant Human IL-7 is designed for ex vivo cell culture processing. No animal- or human-derived materials were used for the manufacture of this product, unless otherwise stated in the respective Certificate of Origin. The product is lyophilized without carrier protein or preservatives.

Detailed product information

Biological activity

Determination method
The specific activity is determined by proliferation assay according to Ishihara et al.1 using mouse 2E8 cells. The proliferation assay was calibrated with the reference standard for human IL-7 (NIBSC code 90/530) provided by the National Institute for Biological Standards and Control.
Minimal specific activity
≥ 5×107 U/mg
Typical specific activity
≥ 1.3×108 U/mg
Background information

The primary sources of IL-7 are non-hematopoietic stromal cells in bone marrow, thymus, and lymphoid organs and tissues. IL-7 is a member of the type I cytokine family. It is related to IL-2 and signals through a heterodimeric receptor composed of the common cytokine signaling γ-chain and IL-7 receptor α-chain.

Applications

MACS GMP Recombinant Human IL-7 can be used for a variety of applications, including the ex vivo generation of antigen-specific cytotoxic T lymphocytes.2,3

Technical specifications

  • Identity/ Molecular mass: 17.382 Da, determined by mass spectrometry. This corresponds to the mature form of human IL-7 (152 amino acids).
  • Purity: ≥ 95 % as determined by chip electrophoresis.
  • Endotoxin content: < 100 EU/mg, as determined by kinetic Limulus Amoebocyte Lysate (LAL) assay (Pharmacopoeia Europaea (Ph. Eur.)).
  • Residual host cell DNA content: < 20 ng/mg, as determined by quantitative PCR specific for E. coli genomic DNA.
  • Residual host cell protein content: < 5 µg/mg, as determined by E. coli HCP ELISA.

The product quality certificate of MACS® GMP Recombinant Human IL-7 was adapted. Learn more here

Quality statement

MACS GMP Products are manufactured and tested under a quality management system (ISO 13485) and are in compliance with relevant GMP guidelines. They are designed following the recommendations of USP <1043> on ancillary materials.

Disclaimer

MACS GMP Products are for ex vivo cell processing only, and are not intended for human in vivo applications. For regulatory status in the USA, please contact your local representative.

Citations for MACS® GMP Recombinant Human IL-7
Publications
  1. Ishihara, K. et al. (1991) Stromal-cell and cytokine-dependent lymphocyte clones which span the pre-B-to B-cell transition. Dev. Immunol. 1: 149-161
  2. Zhang, H. et al. (2007) 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy. J Immunol 179: 4910-4918
  3. Kaneko, S. et al. (2009) IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes. Blood 113: 1006-1015

You have previously chosen International as your location.
What do you want to do?